Yajun Miao - Publications

CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma.

Journal: Frontiers in immunology

Published: November 28, 2025

Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer.

Journal: American journal of cancer research

Published: November 24, 2025

Long-Distance Free-Space Quantum Key Distribution with Continuous Variables.

Journal: Physical review letters

Published: July 11, 2025

Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 01, 2023

Clinical Efficacy of Pyrotinib Combined with Capecitabine in the Second-Line or Above Treatment for HER-2 Positive Advanced Breast Cancer and Its Association with Cell-Free DNA.

Journal: Journal of oncology

Published: August 12, 2022

The molecular mechanism of long non-coding ribonucleic acid (lncRNA) RUNX1-IT1 promotes the proliferation and stemness of lung cancer cells.

Journal: Translational cancer research

Published: September 16, 2021

The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: August 27, 2019

Clinical value of plasma cfDNA concentration and integrity in breast cancer patients.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: April 16, 2019

HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.

Journal: Oncology reports

Published: March 03, 2016